MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
about
Database of T cell-defined human tumor antigens: the 2013 updateAdvances in the treatment of metastatic melanoma: adoptive T-cell therapyCTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeFolding of matrix metalloproteinase-2 prevents endogenous generation of MHC class-I restricted epitopeMELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyThe melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylationSuccessful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.Trial Watch: Adoptive cell transfer immunotherapy.PD-1 expression conditions T cell avidity within an antigen-specific repertoire.A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma.IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survivalInsights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Is antigen specificity the key to efficient adoptive T-cell therapy?Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?Lessons from cancer immunoediting in cutaneous melanoma.Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.Mammalian Polycistronic mRNAs and Disease.Comparison of three culture media for the establishment of melanoma cell lines.Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.High frequency of T cells specific for cryptic epitopes in melanoma patientsMelanoma vaccines and modulation of the immune system in the clinical setting: building from new realities.PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
P2860
Q27022422-527260D5-7B68-41D7-9C4D-0F43F84E27E5Q27027803-8520C2D3-2888-4F49-9440-33B180E95B81Q31010282-E30F8371-4B3E-4ADD-8F0C-48E09BF8DB13Q33650907-B1C481B7-FD7B-4487-8AA5-70A2FC5CC600Q34034978-B0DB8D2F-DA5C-4F4C-8775-2D4C318CA8F5Q34594769-D2A8B04F-D138-4C78-BB86-A96C52B7EB13Q35005458-C3F08B01-A33F-4E80-9DE0-C477CD9F4B35Q35005621-9EBED45C-6320-40D8-BD2B-C3690A35AEF7Q35057739-D942CF41-E296-45FE-9F2D-B52DAD765C70Q35105393-E4A9497F-07EF-4040-ABC1-7055CDD32079Q36057432-885108AB-F200-47BF-B07B-6DB7D549E1B2Q36597350-4E055B2D-1DFC-492B-AEFA-ABE1EBA81759Q37249766-13101400-98BB-47D0-AE24-AD6D19B631A7Q37644925-7D7409E8-30A1-42D2-9BCA-7AA678F55EF4Q37704778-3AD9DA14-B029-40B7-994E-FF4322885A85Q37851050-7F73DD2D-026F-4E47-B969-561C2203B917Q37861214-7DB0E0F6-0A80-4426-91BD-C25655DF6E1FQ37986559-18972E73-D1EB-4796-AFDF-D25F5B67DEA1Q38038176-8245DB50-2CC4-4101-B5F1-25A6195E02A9Q38636573-B105DBA3-CF7E-4454-8A71-411C4870A4FBQ39052581-7970DEFD-A722-439D-ADB4-E5263005C6F9Q41436475-CB2FCEAD-CA3A-4E61-A6B8-847CDB0DFDA5Q42003336-407A115D-72F0-4BCA-8096-7157D3313790Q42141424-2FE6805C-8E68-409E-801D-24ECCF30CE9EQ42145973-ADD56FF8-5561-4586-BACD-19EF3366B5EFQ47137043-EDD94946-86ED-4F7B-9670-1981E7E34DFF
P2860
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@ast
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@en
type
label
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@ast
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@en
prefLabel
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@ast
MELOE-1 is a new antigen overe ...... ve T cell transfer efficiency.
@en
P2093
P2860
P50
P356
P1476
MELOE-1 is a new antigen overe ...... ive T cell transfer efficiency
@en
P2093
Amir Khammari
Brigitte Dreno
Francine Jotereau
Nathalie Labarriere
Yannik Guilloux
P2860
P304
P356
10.1084/JEM.20081356
P407
P577
2008-10-20T00:00:00Z